Estrella Immunopharma Inc. (ESLA) — Defensive Interval Ratio

Latest as of September 2025: 11 days

Estrella Immunopharma Inc. (ESLA) has a Defensive Interval Ratio of 11 days as of September 2025. Defensive assets of $396.90K (cash $-, short-term investments $-, receivables $396.90K) cover 11 days of daily cash needs of $36.60K/day. Check tangible equity quality of Estrella Immunopharma Inc. to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

11 days
Days of operational coverage

Defensive Assets

$396.90K
Cash + ST Investments + Receivables

Daily Cash Need

$36.60K
Current Liabilities ÷ 365

Current Liabilities

$13.36 Million
USD

Estrella Immunopharma Inc. Defensive Interval Ratio (2022–2024)

This chart shows how Estrella Immunopharma Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2022 to 2024. As of September 2025, the ratio stands at 11 days, meaning defensive assets of $396.90K can fund 11 days of operations without new revenue. Also explore Estrella Immunopharma Inc. (ESLA) equity growth momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Estrella Immunopharma Inc. (2022–2024)

The table below presents the year-by-year Defensive Interval Ratio for Estrella Immunopharma Inc. from 2022 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ESLA stock market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 35 days $288.76K $8.21K/day $- $- ▼ -58 days
2022 93 days $273.07K $2.94K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)